Downregulation of LPXN expression by siRNA decreases the malignant proliferation and transmembrane invasion of SHI-1 cells

por Zhu, Guo-Hua, Dai, Hai-Ping, Shen, Qun, Zhang, Qi
Publicado 2019

MRD-Negative Remission Induced in EP300-ZNF384 Positive B-ALL Patients by Tandem CD19/CD22 CAR T-Cell Therapy Bridging to Allogeneic Stem Cell Transplantation

por Zhang, Xin-Yue, Dai, Hai-Ping, Zhang, Ling, Liu, Si-Ning, Dai, Yin, Wu, De-Pei, Tang, Xiao-Wen
Publicado 2021

MiR-130a is aberrantly overexpressed in adult acute myeloid leukemia with t(8;21) and its suppression induces AML cell death

por Ding, Chao, Chen, Su-Ning, Macleod, Roderick A. F., Drexler, Hans G., Nagel, Stefan, Wu, De-Pei, Sun, Ai-Ning, Dai, Hai-Ping
Publicado 2018

Efficacy of ruxolitinib in a patient with myelodysplastic/myeloproliferative neoplasm unclassifiable and co-mutated JAK2, SF3B1 and TP53

por Wang, Qian, Dai, Hai-ping, Liu, Dan-dan, Xie, Jun-dan, Yao, Hong, Ding, Zi-xuan, Tao, Ting-ting, Chen, Su-ning, Zhang, Ri
Publicado 2020

Haploidentical CD7 CAR T-cells induced remission in a patient with TP53 mutated relapsed and refractory early T-cell precursor lymphoblastic leukemia/lymphoma

por Dai, Hai-ping, Cui, Wei, Cui, Qing-ya, Zhu, Wen-juan, Meng, Hui-min, Zhu, Min-qing, Zhu, Xia-ming, Yang, Lin, Wu, De-pei, Tang, Xiao-wen
Publicado 2022

CAR-T cell therapy followed by allogenic hematopoietic stem cell transplantation yielded comparable outcome between Ph like ALL and other high-risk ALL

por Dai, Hai-ping, Kong, Dan-qing, Shen, Hong-jie, Cui, Wei, Wang, Qian, Li, Zheng, Yin, Jia, Kang, Li-qing, Yu, Lei, Wu, De-pei, Tang, Xiao-wen
Publicado 2023

Case Report: Blinatumomab therapy for the treatment of B-cell acute lymphoblastic leukemia patients with central nervous system infiltration

por Cao, Han-Yu, Chen, Hui, Liu, Song-Bai, Gong, Wen-Jie, Qian, Chong-Sheng, Zhang, Tong-Tong, Wan, Chao-Ling, Huang, Si-Man, Xu, Nan, Dai, Hai-Ping, Xue, Sheng-Li
Publicado 2023

Rapid Molecular Response to Dasatinib in a Pediatric Relapsed Acute Lymphoblastic Leukemia With NCOR1-LYN Fusion

por Dai, Hai-Ping, Yin, Jia, Li, Zheng, Yang, Chun-Xiao, Cao, Tin, Chen, Ping, Zong, Yun-Hui, Zhu, Ming-Qing, Zhu, Xia-Ming, Xiao, Sheng, Wu, De-Pei, Tang, Xiao-Wen
Publicado 2020

A Recurrent Cryptic MED14-HOXA9 Rearrangement in an Adult Patient With Mixed-Phenotype Acute Leukemia, T/myeloid, NOS

por Wang, Qian, Zhang, Ling, Zhu, Ming-qing, Zeng, Zhao, Fang, Bao-zhi, Xie, Jun-dan, Pan, Jin-lan, Wu, Chun-xiao, Wu, Ni, Zhang, Ri, Chen, Su-ning, Dai, Hai-ping
Publicado 2021

Efficacy and safety of decitabine combined with HAAG (homoharringtonine, aclarubicin, low-dose cytarabine and G-CSF) for newly diagnosed acute myeloid leukemia

por Zhu, Jun-Feng, Dai, Hai-Ping, Zhang, Qian-Qian, Yin, Jia, Li, Zheng, Cui, Qin-Ya, Tian, Xiao-Peng, Liu, Si-Ning, Jin, Zheng-Ming, Zhu, Xia-Ming, Wu, De-Pei, Tang, Xiao-Wen
Publicado 2022

Identification of STRBP as a Novel JAK2 Fusion Partner Gene in a Young Adult With Philadelphia Chromosome-Like B-Lymphoblastic Leukemia

por Zhang, Xin-Yue, Dai, Hai-Ping, Li, Zheng, Yin, Jia, Lang, Xing-Ping, Yang, Chun-Xiao, Xiao, Sheng, Zhu, Ming-Qing, Liu, Dan-Dan, Liu, Hong, Shen, Hong-Jie, Wu, De-Pei, Tang, Xiao-Wen
Publicado 2021

Venetoclax plus hypomethylating agents in newly diagnosed acute myeloid leukemia patients with RUNX1::RUNX1T1: a retrospective propensity score matching study

por Wang, Miao, Cao, Han-Yu, Tan, Kai-Wen, Qiu, Qiao-Cheng, Huang, Yuan-Hong, Ge, Shuai-shuai, Wang, Zi-Hao, Chen, Jia, Tang, Xiao-Wen, Wu, De-Pei, Xue, Sheng-Li, Li, Zheng, Dai, Hai-Ping
Publicado 2023